Samsung Biologics Co.,Ltd. Financials

Market Capitalization ₩73.879 Trillion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE
Forward PE	45.86
Price to Sales TTM	₩15.08
Price to Book MRQ	₩
Enterprise to Revenue	14.44
Enterprise to EBITDA	32.09

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	26.12%
Operating Margin	37.49%
Return on Assets TTM	5.84%
Return on Equity TTM	12.02%

Income Statement

Revenue TTM	₩4,898,691,743,744
Revenue per Share TTM	₩68826.98
Quarterly Revenue Growth	37.10%
Gross Profit TTM	₩2,583,922,737,152
EBITDA	₩2,399,353,440,150
Net Income to Common TTM	₩1,279,507,693,568
Diluted EPS TTM	₩
Quarterly Earnings Growth YoY	109.40%

Balance Sheet

Total Cash MRQ	₩1,285,235,408,896
Total Cash per Share MRQ	₩18057.65
Total Debt MRQ	₩
Total Debt to Equity MRQ	12.58
Current Ratio MRQ	1.45
Book Value per Share MRQ	₩

Cash Flow

Operating Cash Flow TTM	₩2,052,393,664,512
Levered Free Cash Flow TTM	₩-707,880,681,472

207940 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	71,174,000
Float Shares	18,163,605
Avg 10 Volume	63,473
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	74.42%
% Held by Institutions	14.47%

Stock Price Summary

Beta	0.31
Fifty Two Week Low	₩784000.00
Fifty Two Week High	₩1209000.00
Fifty Two Week Change	23.70%
Day 50 MA	₩1029000.00
Day 200 MA	₩1033400.00

Dividends and Splits

Forward Annual Dividend Rate	₩
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	₩
Trailing Annual Dividend Yield	%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date